64 related articles for article (PubMed ID: 26854063)
1. Glutamate E15 and E171 are Hotspots in p60TRP-Related Cancer.
Kutzner A; Heese K
Cancer Invest; 2016; 34(2):64-9. PubMed ID: 26854063
[TBL] [Abstract][Full Text] [Related]
2. 3D Structure, Dimerization Modeling, and Lead Discovery by Ligand-protein Interaction Analysis of p60 Transcription Regulator Protein (p60TRP).
Pramanik S; Kutzner A; Heese K
Mol Inform; 2016 Apr; 35(3-4):99-108. PubMed ID: 27491919
[TBL] [Abstract][Full Text] [Related]
3. Brain-site-specific proteome changes induced by neuronal P60TRP expression.
Manavalan A; Mishra M; Sze SK; Heese K
Neurosignals; 2013; 21(3-4):129-49. PubMed ID: 23391701
[TBL] [Abstract][Full Text] [Related]
4. Age-related somatic mutations in the cancer genome.
Milholland B; Auton A; Suh Y; Vijg J
Oncotarget; 2015 Sep; 6(28):24627-35. PubMed ID: 26384365
[TBL] [Abstract][Full Text] [Related]
5. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM
World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368
[TBL] [Abstract][Full Text] [Related]
6. Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
Chang MT; Asthana S; Gao SP; Lee BH; Chapman JS; Kandoth C; Gao J; Socci ND; Solit DB; Olshen AB; Schultz N; Taylor BS
Nat Biotechnol; 2016 Feb; 34(2):155-63. PubMed ID: 26619011
[TBL] [Abstract][Full Text] [Related]
7. Using Somatic Mutations to Guide Treatment Decisions: Context Matters.
Horlings HM; Shah SP; Huntsman DG
JAMA Oncol; 2015 Jun; 1(3):275-6. PubMed ID: 26181166
[No Abstract] [Full Text] [Related]
8. Characterizing the new transcription regulator protein p60TRP.
Heese K; Yamada T; Akatsu H; Yamamoto T; Kosaka K; Nagai Y; Sawada T
J Cell Biochem; 2004 Apr; 91(5):1030-42. PubMed ID: 15034937
[TBL] [Abstract][Full Text] [Related]
9. Anticipating designer drug-resistant cancer cells.
Frangione ML; Lockhart JH; Morton DT; Pava LM; Blanck G
Drug Discov Today; 2015 Jul; 20(7):790-3. PubMed ID: 25697478
[TBL] [Abstract][Full Text] [Related]
10. Bioinformatics approaches to cancer gene discovery.
Narayanan R
Methods Mol Biol; 2007; 360():13-31. PubMed ID: 17172723
[TBL] [Abstract][Full Text] [Related]
11. G proteins, p60TRP, and neurodegenerative diseases.
Heese K
Mol Neurobiol; 2013 Jun; 47(3):1103-11. PubMed ID: 23345134
[TBL] [Abstract][Full Text] [Related]
12. Neuronal p60TRP expression modulates cardiac capacity.
Mishra M; Manavalan A; Sze SK; Heese K
J Proteomics; 2012 Feb; 75(5):1600-17. PubMed ID: 22172954
[TBL] [Abstract][Full Text] [Related]
13. Regulator of G-protein signaling (RGS) proteins in cancer biology.
Hurst JH; Hooks SB
Biochem Pharmacol; 2009 Nov; 78(10):1289-97. PubMed ID: 19559677
[TBL] [Abstract][Full Text] [Related]
14. Opposing effects of HIF1α and HIF2α on chromaffin cell phenotypic features and tumor cell proliferation: Insights from MYC-associated factor X.
Qin N; de Cubas AA; Garcia-Martin R; Richter S; Peitzsch M; Menschikowski M; Lenders JW; Timmers HJ; Mannelli M; Opocher G; Economopoulou M; Siegert G; Chavakis T; Pacak K; Robledo M; Eisenhofer G
Int J Cancer; 2014 Nov; 135(9):2054-64. PubMed ID: 24676840
[TBL] [Abstract][Full Text] [Related]
15. Uncovering the genomic heterogeneity of multifocal breast cancer.
Desmedt C; Fumagalli D; Pietri E; Zoppoli G; Brown D; Nik-Zainal S; Gundem G; Rothé F; Majjaj S; Garuti A; Carminati E; Loi S; Van Brussel T; Boeckx B; Maetens M; Mudie L; Vincent D; Kheddoumi N; Serra L; Massa I; Ballestrero A; Amadori D; Salgado R; de Wind A; Lambrechts D; Piccart M; Larsimont D; Campbell PJ; Sotiriou C
J Pathol; 2015 Aug; 236(4):457-66. PubMed ID: 25850943
[TBL] [Abstract][Full Text] [Related]
16. Cancer subtype identification using somatic mutation data.
Kuijjer ML; Paulson JN; Salzman P; Ding W; Quackenbush J
Br J Cancer; 2018 May; 118(11):1492-1501. PubMed ID: 29765148
[TBL] [Abstract][Full Text] [Related]
17. Identifying mutation specific cancer pathways using a structurally resolved protein interaction network.
Engin HB; Hofree M; Carter H
Pac Symp Biocomput; 2015; 20():84-95. PubMed ID: 25592571
[TBL] [Abstract][Full Text] [Related]
18. Discovery of mutated subnetworks associated with clinical data in cancer.
Vandin F; Clay P; Upfal E; Raphael BJ
Pac Symp Biocomput; 2012; ():55-66. PubMed ID: 22174262
[TBL] [Abstract][Full Text] [Related]
19. JAMA Oncology Patient Page. The Evolution of a Cancer.
West HJ; Jin JO
JAMA Oncol; 2015 Sep; 1(6):850. PubMed ID: 26247697
[No Abstract] [Full Text] [Related]
20. Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database.
Petitjean A; Mathe E; Kato S; Ishioka C; Tavtigian SV; Hainaut P; Olivier M
Hum Mutat; 2007 Jun; 28(6):622-9. PubMed ID: 17311302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
